Valeant Pharmaceuticals to Announce 2010 First Quarter Results on May 3, 2010

April 23, 2010

ALISO VIEJO, Calif., April 23, 2010 /PRNewswire via COMTEX/ --Valeant Pharmaceuticals International (NYSE: VRX) today announced that it will host a conference call and a live Internet webcast along with a slide presentation on Monday, May 3, 2010 at 11:00 a.m. EDT (8:00 a.m. PDT) to discuss results for the 2010 first quarter.

The dial-in number to participate on this call is (877) 295-5743, confirmation code68923004. International callers should dial (973) 200-3961, confirmation code 68923004. A replay will be available approximately two hours following the conclusion of the conference call to Monday, May 10, 2010, and can be accessed by dialing (800) 642-1687 or (706) 645-9291, confirmation code 68923004.

The webcast and slide presentation will be hosted in the investor relations section of its corporate Web site at www.valeant.com. Participants should allow approximately five to 10 minutes prior to the call's start time to visit the site and to download any streaming media software needed to listen to the Internet webcast. An online archive of the webcast will be available following the end of the live call in the webcast archive portion of the investor relations section at www.valeant.com.

About Valeant

Valeant Pharmaceuticals International (NYSE: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology. More information about Valeant can be found at http://www.valeant.com/.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081125/VALEANTLOGO)

Contact:
Laurie W. Little, Valeant Pharmaceuticals
949-461-6002